The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study
scholarly article by Ewa Janczewska et al published 16 November 2018 in BMC Infectious Diseases
Author/s
author: Ewa Janczewska, Waldemar Halota, Robert Flisiak, Krzysztof Simon, Andrzej Horban, Krzysztof Tomasiewicz, Jerzy Jaroszewicz, Aleksander Garlicki, Magdalena Tudrujek-Zdunek, Dorota Zarębska-Michaluk, Marta Wawrzynowicz-Syczewska, Hanna Berak, Jolanta Białkowska-Warzecha, Jolanta Citko, Marek Sitko, Łukasz Laurans, Dorota Dybowska, Zbigniew Deroń, Teresa Belica-Wdowik, Beata Lorenc, Anna Piekarska, Andrzej Gietka, Barbara Baka-Ćwierz, Agnieszka Czauż-Andrzejuk, Olga Tronina, Brygida Adamek
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.